GE Healthcare recently announced its acquisition of Intelerad Medical Systems, a leader in enterprise imaging solutions, for a staggering $2.3 billion. This move is seen as a strategic decision by GE Healthcare to strengthen its position in the rapidly growing digital healthcare market.
In a press release, GE Healthcare stated that the acquisition of Intelerad will enhance its ability to provide comprehensive imaging solutions to healthcare providers around the world. Intelerad’s advanced technology and expertise in enterprise imaging will complement GE Healthcare’s existing portfolio of products and services, allowing the company to offer a more integrated and seamless experience for its customers.
Intelerad, founded in 1999, has established itself as a trusted provider of imaging solutions for healthcare organizations of all sizes. The company’s cloud-based platform enables healthcare providers to store, view, and share medical images securely and efficiently. With over 400 employees and a presence in more than 100 countries, Intelerad has built a strong reputation for innovation and customer service.
The acquisition of Intelerad is part of GE Healthcare’s broader strategy to expand its digital healthcare offerings and drive growth in key markets. By combining Intelerad’s technology with its own expertise in medical imaging, GE Healthcare aims to deliver a more comprehensive suite of solutions to its customers, helping them improve patient care and operational efficiency.
In the press release announcing the acquisition, Kieran Murphy, President and CEO of GE Healthcare, highlighted the importance of digital innovation in healthcare. “The acquisition of Intelerad is a significant milestone for GE Healthcare as we continue to invest in technologies that will shape the future of healthcare,” Murphy said. “By bringing together the strengths of GE Healthcare and Intelerad, we will be able to offer our customers a more complete and integrated solution for managing medical imaging data.”
The acquisition of Intelerad is subject to regulatory approval and is expected to close in the first quarter of 2022. Once completed, GE Healthcare will integrate Intelerad’s technology and team into its existing business, further strengthening its position as a leader in the digital healthcare market.
Overall, GE Healthcare’s acquisition of Intelerad represents a significant investment in the future of healthcare technology. By combining their respective strengths, the two companies will be able to offer a more comprehensive and innovative suite of solutions to healthcare providers worldwide, ultimately benefiting patients and healthcare organizations alike.
************
Want to get more details?
Doctors In Business Journal
https://www.doctorsinbusinessjournal.com/
San Francisco, CA
